Scientists created a special two-part gel that can be sprayed onto diabetic wounds to help them heal better. The gel works by reducing inflammation and harmful chemicals in the wound while keeping it moist and protected. In tests on mice with diabetes, the gel helped wounds close faster and grow new healthy skin. This new treatment could eventually help millions of people with diabetes who struggle with slow-healing wounds that sometimes become serious infections.
The Quick Take
- What they studied: Whether a new two-part spray gel could help diabetic wounds heal faster by reducing inflammation and harmful chemicals while protecting the wound
- Who participated: Laboratory tests using cells and mice with diabetes; no human participants were involved in this study
- Key finding: The new gel (called AGBS-IG) significantly sped up wound healing in diabetic mice, helping wounds close faster and grow new skin tissue more effectively than untreated wounds
- What it means for you: This research is early-stage and shows promise for future diabetic wound treatments, but it hasn’t been tested on humans yet. If further testing succeeds, it could eventually offer a better option for people with diabetes who have trouble healing wounds
The Research Details
Researchers created a special gel using two components that work together. The first component is a liquid mixture that can be injected into irregular wound shapes and contains ingredients that reduce inflammation. The second component is a spray that hardens the liquid into a gel and contains powerful antioxidants (substances that fight harmful chemicals). The gel has a spongy inside to absorb wound fluid and a smooth outside to protect the wound and keep it moist.
The scientists tested this gel in two ways: first, they tested it in dishes with human cells to see if it was safe and effective, and second, they tested it on mice that had diabetes to see if it actually helped wounds heal. They measured things like how fast the wound closed, how much new skin grew, and how much inflammation and harmful chemicals were present.
This research approach is important because diabetic wounds are a major health problem. People with diabetes often have wounds that heal very slowly or don’t heal at all, which can lead to serious infections and even amputation. Most current treatments don’t address the root causes—too much inflammation and harmful chemical damage. This new gel tackles both problems at once, which is why the approach matters.
This is laboratory and animal research, which is an important first step but doesn’t prove the treatment will work in humans. The study was published in a peer-reviewed scientific journal, meaning other experts reviewed it. However, readers should know that animal studies don’t always translate to human results, and human clinical trials would be needed before this could be used as a medical treatment.
What the Results Show
In laboratory tests with cells, the gel was safe and didn’t harm healthy cells. The gel effectively reduced harmful chemicals called reactive oxygen species that damage wounds. It also reduced inflammatory signals that normally slow healing in diabetic wounds. The gel helped immune cells shift toward a healing mode rather than a damaging mode.
When tested on mice with diabetes, the gel produced impressive results. Wounds treated with the gel closed significantly faster than untreated wounds. The new skin that grew back was healthier and more complete, with better collagen (the protein that gives skin strength) and even restoration of hair follicles and sweat glands. The treated wounds showed much less oxidative stress and fewer harmful compounds that accumulate in diabetic wounds.
The gel also helped blood vessel cells and skin-building cells (fibroblasts) move into the wound area and multiply, which are both essential for healing. The gel’s structure—with its spongy inside and smooth outside—worked well for absorbing wound fluid while maintaining a moist environment, which is known to promote healing. The two-component system proved practical because it could conform to irregular wound shapes.
Current diabetic wound treatments typically focus on either keeping wounds moist or fighting infection, but don’t address the underlying inflammation and oxidative stress problems. This gel is novel because it tackles multiple problems simultaneously. Previous research has shown that reducing inflammation and oxidative stress helps wounds heal, but this is one of the first attempts to combine these benefits in a practical spray-on format designed specifically for diabetic wounds.
This study only tested the gel in laboratory dishes and on mice, not on humans. Mouse diabetes and wounds don’t perfectly match human diabetes and wounds. The study didn’t compare the gel directly to current standard treatments, so we don’t know if it’s better than what doctors use now. The long-term effects and how long the gel stays effective on a wound aren’t fully explored. Before this could be used on patients, it would need to pass safety and effectiveness tests in human clinical trials.
The Bottom Line
This research is too early-stage to recommend for human use. It shows promise and suggests future potential, but people with diabetic wounds should continue following their doctor’s current treatment plans. If you have a diabetic wound, work with your healthcare provider on proven treatments while staying aware that new options like this may become available in the future (moderate confidence level—based on promising lab and animal results, but no human data yet).
People with diabetes who have slow-healing wounds, healthcare providers treating diabetic wounds, and researchers developing new wound treatments should follow this research. People without diabetes or those with normally-healing wounds don’t need to apply these findings yet. This is most relevant for people with type 1 or type 2 diabetes who experience chronic wounds.
This research is in early stages. If development continues successfully, it would typically take 5-10 years of additional testing before this could potentially be available as a medical treatment. Human clinical trials would need to happen first, which takes several years.
Want to Apply This Research?
- Users with diabetic wounds could track wound healing progress by measuring wound size weekly (length and width in millimeters), photographing wounds under consistent lighting, and recording pain levels and drainage amounts to share with their healthcare provider
- Set daily reminders to follow current wound care protocols (cleaning, dressing changes, medication) while logging completion in the app; track blood sugar levels since good glucose control improves healing; monitor for signs of infection (increased redness, warmth, pus, odor) and alert healthcare provider immediately if detected
- Create a weekly wound assessment routine: photograph wound, measure dimensions, note drainage type and amount, assess surrounding skin condition, and track any changes in pain or sensation; share monthly summaries with healthcare provider to ensure current treatment is working and adjust if needed
This research describes early-stage laboratory and animal testing of a new wound treatment gel. It has not been tested on humans and is not available as a medical treatment. People with diabetic wounds should continue working with their healthcare providers using proven treatments. This article is for educational purposes only and should not replace professional medical advice. Always consult with a doctor before making changes to wound care or diabetes management.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.